Company News

Share this article:

Sepracor moved creative duties for Lunesta from The Kaplan Thaler Group, a New York-based Publicis shop, to Lowe, an IPG shop, Adweek reported. Prior to The Kaplan Thaler Group, the creative account was handled by IPG's McCann HumanCare.

Bioniche Pharma, a manufacturer of specialty injectables, received a warning letter from DDMAC regarding web pages for Sotradecol (sodium tetradecyl sulfate injection) located on the Bioniche and AngioDynamics websites. The pages “fail to communicate any information about the risks associated with the product,” the letter stated. Bioniche was cited for the same violations in April of 2006. Sotradecol is indicated in the treatment of small, uncomplicated varicose veins.


Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.